Prolonged survival time following initial presentation with bony metastasis in stage IVb endometrial carcinoma

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 43, Issue 3, 2003, Pages 239-240

  Arnold, Joanna ^a   Charters, Deryck ^a   Perrin, Lewis ^a  

^a GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ADENOCARCINOMA; ADULT; ANAMNESIS; ARTICLE; BONE GRAFT; BONE METASTASIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CAUDA EQUINA SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY WARD; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; MYELOGRAPHY; OSTEOSYNTHESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPINAL CORD DECOMPRESSION; SPINE FUSION; SPINE RADIOGRAPHY; SPINE SURGERY; SURVIVAL TIME; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADENOCARCINOMA; BONE NEOPLASMS; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING;

EID: 0037812933     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0004-8666.2003.00050.x     Document Type: Article

References (10)

1. Petersen RW, Quinlivan JA, Casper GR, Nicklin JL. Endometrial adenocarcinoma - presenting pathology is a poor guide to surgical management. Aust NZ J Obstet Gynaecol. 2000; 40: 191-194.
2. Malicky ES, Kostic KJ, Jacob JH, Allen WC. Endometrial carcinoma presenting with an isolated osseous metastasis: a case report and review of the literature. Eur J Gynaecol Oncol. 1997; 18: 492-494.
3. Mustafa MS, Al-Nuaim I, Inayat-Ur-Rahman N. Scalp and cranial bone metastasis of endometrial carcinoma: a case report and literature review. Gynecol Oncol. 2001; 81: 105-109.
4. Yalman D, Ozsaran Z, Anacak Y et al. Postoperative radiotherapy in endometrial carcinoma: analysis of prognostic factors in 440 cases. Eur J Gynaec Oncol. 2000; 21: 311-315.
5. Sahinler I, Erkal H, Akyazici E, Atkovar G, Okkan S. Endometrial carcinoma and an unusual presentation of bone metastasis: a case report. Gynecol Oncol. 2001; 82: 216-218.
6. Dosoretz DE, Orr JW, Salenius SA, Orr PF. Mandibular metastasis in a patient with endometrial cancer. Gynecol Oncol. 1999; 72: 243-245.
7. Rose PG. Endometrial carcinoma. N Engl J Med. 1996; 335: 640-649.
8. Bristow RE, Zerbe MJ, Rosenheim NB, Grumbine FC, Montz FJ. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol. 2000; 78: 85-91.
9. Elit L, Hirte H. Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer. Curr Opin Obstet Gynecol. 2002; 14: 67-73.
10. Thigpen JT, Brady MF, Alvarez RD et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecological Oncology Group. J Clin Oncol. 1999; 17: 1736-1744.